Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli

被引:108
作者
Woodman, SE
Ashton, AW
Schubert, W
Lee, H
Williams, TM
Medina, FA
Wyckoff, JB
Combs, TP
Lisanti, MP
机构
[1] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Cardiol, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA
[4] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA
[5] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
关键词
D O I
10.1016/S0002-9440(10)64337-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Recent studies have shown that caveolin-1 (Cav-1) plays an important role as a regulator of angiogenesis in vitro. Here, we use Cav-1 knockout (KO) mice as a model system to examine the in vivo relevance of these findings. A primary mediator of angiogenesis is basic fibroblast growth factor (bFGF). Thus, we studied bFGF-induced angiogenesis in Cav-1 KO mice using a reconstituted basement membrane system, ie, Matrigel plugs, supplemented with bFGF. In Cav-1 KO mice, implanted Matrigel plugs showed a dramatic reduction in both vessel infiltration and density, as compared with identical plugs implanted in wild-type control mice. We also examined the necessity of Cav-1 to support the angiogenic response of an exogenous; tumor by subcutaneously injecting Cav-1 KO mice with the melanoma cell line, B16-F10. We show that tumor weight, volume, and vessel density are all reduced in Cav-1 KO mice, consistent with diminished angiogenesis. Ultrastructural analysis of newly formed capillaries within the exogenous tumors reveals a lack of endothelial caveolae and incomplete capillary formation in Cav-1 KO mice. These results provide novel evidence that Cav-1 and caveolae play an important positive role in the process of pathological angiogenesis in vivo. (Am J Pathol 2003, 162:2059-2068)
引用
收藏
页码:2059 / 2068
页数:10
相关论文
共 49 条
[1]   Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization [J].
Bajou, K ;
Noël, A ;
Gerard, RD ;
Masson, V ;
Brunner, N ;
Holst-Hansen, C ;
Skobe, M ;
Fusenig, NE ;
Carmeliet, P ;
Collen, D ;
Foidart, JM .
NATURE MEDICINE, 1998, 4 (08) :923-928
[2]   Biological roles of fibroblast growth factor-2 [J].
Bikfalvi, A ;
Klein, S ;
Pintucci, G ;
Rifkin, DB .
ENDOCRINE REVIEWS, 1997, 18 (01) :26-45
[3]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[4]   ANTIINTEGRIN ALPHA-V-BETA-3 BLOCKS HUMAN BREAST-CANCER GROWTH AND ANGIOGENESIS IN HUMAN SKIN [J].
BROOKS, PC ;
STROMBLAD, S ;
KLEMKE, R ;
VISSCHER, D ;
SARKAR, FH ;
CHERESH, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1815-1822
[5]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[6]   Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation [J].
Capozza, F ;
Williams, TM ;
Schubert, W ;
McClain, S ;
Bouzahzah, B ;
Sotgia, F ;
Lisanti, MP .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) :2029-2039
[7]   Mechanisms of angiogenesis and arteriogenesis [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (04) :389-395
[8]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[9]  
Compagni A, 2000, CANCER RES, V60, P7163
[10]   Molecular mechanisms of blood vessel growth [J].
Conway, EM ;
Collen, D ;
Carmeliet, P .
CARDIOVASCULAR RESEARCH, 2001, 49 (03) :507-521